Antibody developed against the cytoplasmic tail of CD4 just prior to the UGA codon, used as a positive control
| Inventor | Institute |
|---|---|
| Brady Neal Ware | University of Georgia Research Foundation, Inc. |
| Cat. #: | 162348 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Application: | ELISA |
| Reactivity: | Human |
| Host: | Mouse |
| Primary citation: | Ware, 2003, Doctoral Thesis, University of Georgia. "Gene regulation and overlooked coding regions : the case for translation past the 3'-UGA codon in CD4" |
| Product description: | Antibody developed against the cytoplasmic tail of CD4 just prior to the UGA codon, used as a positive control |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgM |
| Immunogen: | Peptide |
| Target background: | The last 20 amino acids of the accepted CD4 cytoplasmic tail. The predicted molecular weight of the peptide for the known region of cytoplasmic tail is 2334.9 Daltons. Peptide has 15 hydrophilic resides |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Ware, 2003, Doctoral Thesis, University of Georgia. "Gene regulation and overlooked coding regions : the case for translation past the 3'-UGA codon in CD4" |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151022 | Anti-IL12 [1-1A4] |
Key Info
Anti-IL12 [1-1A4]
|
View Tool | |||||||||||||||||||
| 151024 | Anti-Hairy [1/24] |
Key Info
Anti-Hairy [1/24]
|
View Tool | |||||||||||||||||||
| 151038 | Anti-Cytochrome P450 4A2, 4A3 [Clo4] |
Key Info
Anti-Cytochrome P450 4A2, 4A3 [Clo4]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.